Keith C. Regnante
2016
In 2016, Keith C. Regnante earned a total compensation of $1.6M as Chief Financial Officer at Wave Life Sciences Ltd..
Compensation breakdown
| Non-Equity Incentive Plan | $48,300 |
|---|---|
| Option Awards | $1,470,919 |
| Salary | $120,000 |
| Other | $331 |
| Total | $1,639,550 |
Regnante received $1.5M in option awards, accounting for 90% of the total pay in 2016.
Regnante also received $48.3K in non-equity incentive plan, $120K in salary and $331 in other compensation.
Rankings
In 2016, Keith C. Regnante's compensation ranked 5,832nd out of 14,075 executives tracked by ExecPay. In other words, Regnante earned more than 58.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,832 out of 14,075 | 59th |
Division Manufacturing | 2,115 out of 5,486 | 61st |
Major group Chemicals And Allied Products | 691 out of 1,900 | 64th |
Industry group Drugs | 520 out of 1,543 | 66th |
Industry Pharmaceutical Preparations | 412 out of 1,173 | 65th |
Source: SEC filing on June 26, 2019.
Regnante's colleagues
We found two more compensation records of executives who worked with Keith C. Regnante at Wave Life Sciences Ltd. in 2016.